Gyre Therapeutics (GYRE) Operating Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -6,827.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,827.00 |
| Dec 31, 2025 | -29.00 |
| Mar 31, 2025 | 186,182.00 |
| Dec 31, 2024 | 83,489.00 |
| Sep 30, 2024 | 111,400.00 |
| Jun 30, 2024 | 177,185.00 |
| Mar 31, 2024 | 155,922.00 |
| Dec 31, 2023 | 59,014.00 |
| Sep 30, 2023 | 184,275.00 |
| Jun 30, 2023 | 106,406.00 |
| Mar 31, 2023 | 5,770.00 |
| Mar 31, 2021 | 10.98 Mn |
| Dec 31, 2020 | 90,535.00 |
| Sep 30, 2020 | 4,552.00 |
| Jun 30, 2020 | 430,785.00 |
| Mar 31, 2020 | 150,815.00 |
| Mar 31, 2018 | -11.09 Mn |
| Dec 31, 2017 | -156,546.00 |
| Sep 30, 2017 | -154,898.00 |
| Jun 30, 2017 | -461,085.00 |
| Mar 31, 2017 | -91,184.00 |
| Dec 31, 2016 | 695,756.00 |
| Mar 31, 2016 | -396,050.00 |
| Dec 31, 2015 | -154,040.00 |
| Sep 30, 2015 | -250,979.00 |
| Jun 30, 2015 | -29,853.00 |
| Mar 31, 2015 | -45,988.00 |
| Dec 31, 2014 | -21,401.00 |
| Sep 30, 2014 | -25,022.00 |
| Jun 30, 2014 | -73,171.00 |
| Mar 31, 2014 | -65,882.00 |
| Dec 31, 2013 | -1.43 Mn |